SUPER-REFRACTORY STATUS EPILEPTICUS
Clinical trials for SUPER-REFRACTORY STATUS EPILEPTICUS explained in plain language.
Never miss a new study
Get alerted when new SUPER-REFRACTORY STATUS EPILEPTICUS trials appear
Sign up with your email to follow new studies for SUPER-REFRACTORY STATUS EPILEPTICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients with Life-Threatening seizures?
Disease control CompletedThis study tested a drug called SAGE-547 in 25 people with super-refractory status epilepticus, a life-threatening condition where seizures don't stop even with strong medications. The main goal was to see if the drug was safe and tolerable when added to standard treatment. The s…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE1, PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
Breakthrough drug may stop deadly seizures when all else fails
Disease control CompletedThis study tested a drug called SAGE-547 in 132 people with super-refractory status epilepticus, a life-threatening condition where seizures don't stop even with strong anesthetics. The goal was to see if SAGE-547 could help patients come off these anesthetics and stay seizure-fr…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC